PHARMERICA INC
15-12G, 1999-04-27
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: GE CAPITAL MORTGAGE SERVICES INC, 424B5, 1999-04-27
Next: COSMETIC CENTER INC, 8-K, 1999-04-27



                                     FORM 15
Certification  and Notice of Termination of Registration  under Section 12(g) of
the Securities  Exchange Act of 1934 or Suspension of Duty to File Reports Under
Section 13 and 15(d) of the Securities Exchange Act of 1934.
                        Commission File Number 000-20606
         -----------------------------------------------------------------------

                                PharMerica, Inc.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                      175 Kelsey Lane, Tampa, Florida 33619
- --------------------------------------------------------------------------------
   (Address, including zip code, and telephone number, including area code, of
                    registrant's principal executive offices)

                     Common Stock, Par Value $.01 Per Share
                   8 3/8% Senior Subordinated Notes Due 2008
- --------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      none
- --------------------------------------------------------------------------------
         (Titles of  all   other   classes   of securities for which a duty to
               file reports under section 13(a) or 15(d) remains)

          Please place an X in the box(es) to  designate  the  appropriate  rule
provisions(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)    [X]             Rule 12h-3(b)(1)(ii)             [ ]
Rule 12g-4(a)(1)(ii)   [ ]             Rule 12h-3(b)(2)(i)              [ ]
Rule 12g-4(a)(2)(i)    [ ]             Rule 12h-3(b)(2)(ii)             [ ]
Rule 12g-4(a)(2)(ii)   [ ]             Rule 15d-6                       [X]
Rule 12h-3(b)(1)(i)    [X]

          Approximate  number of  holders of record as of the  certification  or
notice date: 

Common Stock, Par Value $.01 Per Share: 1
8 3/8% Senior Subordinated Notes Due 2008:  35

          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
PharMerica, Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.

DATE: April 26, 1999                        BY: /s/ Milan A. Sawdei
      -------------------                    -----------------------------------
                                                    Milan A. Sawdei

                                             TITLE:  Secretary

Instruction:  This  form is  required  by Rules  12g-4,  12h-3  and 15d-6 of the
General Rules and  Regulations  under the  Securities  Exchange Act of 1934. The
registrant  shall file with the Commission three copies of Form 15, one of which
shall be manually signed.  It may be signed by an officer of the registrant,  by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission